Moreover, pre-clinical studies suggest that mTOR activation enhances Aβ generation and deposition by modulating amyloid precursor protein (APP) metabolism and upregulating β- and γ-secretases [98], while its inhibition by rapamycin ameliorates AD like conditions [93,99,100]. This evidence concerns the gene APP and Alzheimer disease.